Access cutting-edge heart failure treatment through this clinical trial at a research site in Yuma. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Yuma at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fraction (HFpEF) and HF with mildly reduced ejection fraction (HFmrEF) who are obese. This is a phase 3, global, multicenter, 2-part study with a double-blind period and an open-label extension (OLE). The
Sponsor: Amgen
Check if you qualify for this heart failure clinical trial in Yuma, AZ
If you're searching for heart failure treatment options in Yuma, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Yuma research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.